New hormonal agent may slow progression of early-stage prostate cancer during active surveillance
For men with early-stage prostate cancer being managed by active surveillance, adding the hormonal agent apalutamide may lower the rate of positive biopsies during follow-up, suggests a preliminary clinical trial in the Journal ...
Jan 10, 2023
0
4